Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
Christian Niederwieser(Universität Hamburg), C. D. Bloomfield(Leukemia Research Foundation), Heiko Becker(University of Freiburg), Jason H. Mendler(University of Rochester Medicine), Pearlly S. Yan(The Ohio State University), Klaus H. Metzeler(University Hospital Leipzig), Stefano Volinia(University of Ferrara), David Frankhouser(The Ohio State University), Ralf Bundschuh(The Ohio State University), Maria R. Baer(University of Maryland, Baltimore), Jessica Kohlschmidt(The Ohio State University), Guido Marcucci(City of Hope), Y-Z Wu(The Ohio State University), Sebastian Schwind, Thomas H. Carter(University of Iowa), Richard M. Stone(Dana-Farber Cancer Institute), Richard A. Larson(Urbana University), Joseph O. Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Krzysztof Mrózek(The Ohio State University), A-K Eisfeld(The Ohio State University), Deedra Nicolet(The Ohio State University), John Curfman(University of Maryland, Baltimore), Bayard L. Powell(Atrium Health Wake Forest Baptist), A J Carroll(University of Alabama at Birmingham), Susan P. Whitman(The Ohio State University Wexner Medical Center), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Kati Maharry(Peter MacCallum Cancer Centre)
Cited by 77
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k